Mechanism of heparin action
- PMID: 2176902
- DOI: 10.1016/s0950-3536(05)80015-0
Mechanism of heparin action
Abstract
Heparin catalysis of clotting proteinase inactivation occurs most efficiently through the reaction of the proteinase with the antithrombin-heparin complex. The efficiency of a heparin molecule in this reaction depends on the presence of a specific pentasaccharide sequence in it, and its molecular weight. The mechanism by which such high affinity heparin acts when antithrombin III is the inhibitor is promotion of the formation of an intermediate proteinase-heparin-antithrombin complex. Heparin promotion of thrombin inactivation by heparin cofactor II may occur by a similar mechanism. The requirement for a specific oligosaccharide sequence within the heparin molecule does not, however, exist for heparin cofactor II. Binding of heparin to both thrombin and antithrombin III interferes with thrombin inactivation. This binding is very dependent on the ionic strength of the reaction mixture and may explain some of the discordant results and interpretations from early studies on the mechanism of heparin action. Low ionic strength in in vitro reactions also results in cleavage of antithrombin III by thrombin in the presence of heparin and effectively converts antithrombin III from an inhibitor to a substrate.
Similar articles
-
Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.J Biol Chem. 1992 Jun 25;267(18):12528-38. J Biol Chem. 1992. PMID: 1618758
-
Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.Thromb Haemost. 2004 Nov;92(5):929-39. doi: 10.1160/TH04-06-0384. Thromb Haemost. 2004. PMID: 15543318
-
Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.Can J Biochem Cell Biol. 1984 Oct;62(10):975-83. doi: 10.1139/o84-125. Can J Biochem Cell Biol. 1984. PMID: 6509363
-
Effect of low molecular weight heparin preparations on the inhibition of thrombin by heparin cofactor II.Semin Thromb Hemost. 1990 Oct;16 Suppl:66-70. Semin Thromb Hemost. 1990. PMID: 1962908 Review.
-
Mechanisms of action of low molecular weight heparins and heparinoids.Baillieres Clin Haematol. 1990 Jul;3(3):505-29. doi: 10.1016/s0950-3536(05)80016-2. Baillieres Clin Haematol. 1990. PMID: 1703023 Review. No abstract available.
Cited by
-
Anticoagulant Treatment in Severe ARDS COVID-19 Patients.J Clin Med. 2022 May 10;11(10):2695. doi: 10.3390/jcm11102695. J Clin Med. 2022. PMID: 35628822 Free PMC article. Review.
-
The Effect of Extended Injection of Subcutaneous Heparin on Pain Intensity and Bruising Incidence.Electron Physician. 2016 Jul 25;8(7):2650-4. doi: 10.19082/2650. eCollection 2016 Jul. Electron Physician. 2016. PMID: 27648193 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical